Shan-Shan Chen

Statistics

Publications

Citations

2.5K

H-Index

Active since

2006

Affiliations

Gilead Sciences (United States)(Current)

Chelsea and Westminster Hospital

Johns Hopkins Medicine

Orlando Immunology Center

Johns Hopkins University

Shan-Shan Chen is an author at Gilead Sciences (United States) specializing in antiviral therapy, human immunodeficiency virus pharmacotherapy, and pharmacy.

Publications per year

2006–2016

Publications

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

Mark Nelson, Christine Katlama, David A. Cooper et al. · AIDS · 2007 · 352 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients

José Ramón Arribas, Anton Pozniak, Joel E. Gallant et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 234 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

Anton Pozniak, Joel E. Gallant, Edwin DeJesus et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 232 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients

Joel E. Gallant, Jonathan Winston, Edwin DeJesus et al. · AIDS · 2008 · 125 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 5